These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8999764

  • 21. [Antibiotics, developments and orientation].
    de Marie S, Verbrugh HA.
    Ned Tijdschr Geneeskd; 1992 Apr 04; 136(14):673-8. PubMed ID: 1560853
    [No Abstract] [Full Text] [Related]

  • 22. [The effect of vilozen on the immune status of erysipelas patients and the prospects for its use for the immune rehabilitation of convalescents].
    Frolov VM, Peresadin NA, Pinskiĭ LL, Korobka IuN.
    Lik Sprava; 1992 Apr 04; (11-12):102-4. PubMed ID: 1292201
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Enhancement of the activity of antitubercular agents with other antimicrobial agents].
    Vinogradova TI.
    Probl Tuberk; 1994 Apr 04; (3):59-62. PubMed ID: 7937678
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Immunopharmacology of oral betalactams.
    Periti P.
    J Chemother; 1998 Apr 04; 10(2):91-6. PubMed ID: 9603632
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The new antibiotics, 1997.
    Townsend GC, Mandell GL.
    Va Med Q; 1997 Apr 04; 124(2):108-11. PubMed ID: 9100474
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides.
    Cornick JE, Bentley SD.
    Microbes Infect; 2012 Jul 04; 14(7-8):573-83. PubMed ID: 22342898
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Treatment of pneumonia in a community].
    Lecocq P, Mouton Y.
    Rev Prat; 1993 Feb 15; 43(4):475-9. PubMed ID: 8341915
    [No Abstract] [Full Text] [Related]

  • 35. [Empiric therapy of community-acquired pneumonia: a transatlantic controversy].
    Garin N, Nendaz M.
    Rev Med Suisse; 2006 Jan 25; 2(50):289-90, 292-4. PubMed ID: 16503046
    [Abstract] [Full Text] [Related]

  • 36. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of community-acquired respiratory tract infections.
    Calbo E, Garau J.
    Respiration; 2005 Jan 25; 72(6):561-71. PubMed ID: 16354997
    [Abstract] [Full Text] [Related]

  • 37. New antibacterial agents.
    Hussar DA.
    Am Pharm; 1993 Jan 25; NS33(1):41-6. PubMed ID: 8430618
    [Abstract] [Full Text] [Related]

  • 38. The use of oral antibiotics in lower-extremity infections.
    Joseph WS, Lefrock J.
    Clin Podiatr Med Surg; 1996 Oct 25; 13(4):683-99. PubMed ID: 8902339
    [Abstract] [Full Text] [Related]

  • 39. [Advances in antimicrobial therapy].
    Rodríguez WJ.
    An Esp Pediatr; 1992 Jun 25; 36 Suppl 48():132-4. PubMed ID: 1636949
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.